Rationing Medications: How Ethical Decisions Are Made During Drug Shortages

Stephen Roberts 14 March 2026 13 Comments

When a life-saving drug runs out, who gets it? This isn’t a hypothetical question. In 2023, over 300 drugs were in short supply across the U.S., including critical cancer treatments like carboplatin and cisplatin. Hospitals had to make decisions no doctor should ever face: which patient gets the next dose, and which one doesn’t. These aren’t random choices. Behind every rationing decision is a complex, often painful, ethical framework designed to be fair - but in practice, it’s far from consistent.

Why Medication Rationing Happens

Drug shortages aren’t new, but they’ve become routine. In 2005, there were 61 reported shortages. By 2023, that number jumped to 319. The biggest culprits? Generic injectable drugs - especially those used in cancer care, intensive care, and emergency medicine. Why? Because these drugs are cheap to make, have low profit margins, and rely on a handful of manufacturers. Just three companies produce 80% of the generic sterile injectables used in U.S. hospitals. If one factory shuts down for maintenance, fails an inspection, or runs out of raw materials, hundreds of hospitals feel the ripple effect.

Oncology drugs are hit hardest. Between March and August 2023, 70% of U.S. cancer centers reported severe shortages of carboplatin and cisplatin. These aren’t optional medications. For many patients, they’re the only treatment that can stop cancer from spreading. When they’re gone, doctors don’t just delay care - they have to choose.

The Ethical Frameworks That Guide Decisions

No hospital wants to make these calls alone. That’s why ethical frameworks exist. They’re not perfect, but they’re meant to stop decisions from being made in the heat of the moment by one overwhelmed clinician.

The most widely accepted model comes from bioethicists Daniel and Sabin. It’s called Accountability for Reasonableness a framework requiring four conditions: transparency, relevance, appeal, and enforcement. Here’s what that means in practice:

Transparency: Everyone - patients, families, staff - must know how decisions are made.
Relevance: Criteria must be based on medical evidence, not gut feeling. For example, prioritizing patients with a higher chance of survival.
Appeal: There must be a way to challenge a decision if someone feels it’s unfair.
Enforcement: Someone has to make sure the rules are followed.

The American Society of Clinical Oncology (ASCO) built on this with specific rules for cancer care. Their 2023 guidance says allocation decisions must happen at the institutional level - not at the bedside. A committee, not a single doctor, should decide. And patients must be told.

How Rationing Criteria Work in Real Life

Different hospitals use different rules. But most follow a set of five core criteria, first outlined in the American Journal of Bioethics a 2012 framework that defines five key allocation principles for scarce medical resources:

Urgency of need: Who will die without this drug right now?
Chance of benefit: Who is most likely to respond?
Duration of benefit: Will this drug extend life for months - or just weeks?
Years of life saved: Should we prioritize a 25-year-old over a 75-year-old if both have equal survival chances?
Instrumental value: Should frontline workers get priority? (Some hospitals do, especially during pandemics.)

Minnesota’s 2023 guidelines for carboplatin and cisplatin went even further. They created a tiered system:

Tier 1: Curative intent treatment with no alternative. (e.g., a young patient with testicular cancer who can’t be treated with anything else.)
Tier 2: Palliative intent with high survival benefit. (e.g., someone with advanced ovarian cancer where this drug improves survival by 4-6 months.)
Tier 3: Maintenance therapy or low-benefit use. (e.g., routine follow-up dosing with minimal impact.)

This isn’t just theory. Hospitals using these systems saw a 41% drop in clinician burnout, according to a 2022 Mayo Clinic study. Why? Because doctors weren’t carrying the weight alone.

A diverse hospital ethics committee reviews allocation criteria under warm lantern light, with patients waiting outside in the rain.

The Gap Between Policy and Practice

Here’s the hard truth: most hospitals don’t follow these rules.

A 2022 survey of 247 pharmacy managers found that 51.8% of rationing decisions were made at the bedside - by one doctor, with no committee, no oversight. Only 13.3% of hospitals had committees that included physicians. Just 2.8% included ethicists. And only 4.9% had anyone trained in ethics.

That’s dangerous. Bedside rationing leads to inconsistent outcomes. One hospital might prioritize younger patients. Another might give priority to those who arrived first. A third might favor patients with better insurance. No standard. No transparency.

Worse, 64% of patients were never told their treatment was rationed. A 2021 Patient Advocate Foundation study recorded 127 formal complaints from families who only found out after the fact - or never at all.

Even when committees exist, they’re slow. It takes an average of 72 hours from the time a shortage is declared to when the committee meets. In emergency cases - like a patient in septic shock needing an antibiotic - that delay can be fatal.

Who Gets Left Behind?

The biggest failure of current rationing systems? They ignore equity.

A 2021 Hastings Center Report found that 78% of hospital rationing protocols don’t include any explicit measures to protect marginalized groups - Black, Hispanic, low-income, or rural patients. Why does this matter? Because these groups are already more likely to face delays in care, less access to specialists, and fewer resources to navigate complex systems.

Rural hospitals are hit hardest. A 2022 ASHP survey showed 68% of rural facilities had no formal rationing plan. Meanwhile, academic medical centers - with ethicists, pharmacists, and social workers on staff - were far more likely to have structured protocols.

And then there’s the hoarding. A 2018 survey found that 68% of hospitals reported departments - like oncology or ICU - hoarding drugs, keeping extra vials for their own patients, even when others were in crisis. It’s not greed. It’s fear. But it makes the shortage worse for everyone.

A rural clinic’s empty drug shelf contrasts with a well-resourced hospital’s ethical committee, connected by a crumbling bridge of bottles.

What’s Being Done to Fix It

Change is coming - slowly. In 2023, ASCO launched a free online decision tool to help oncologists navigate shortages. The CDC updated its Crisis Standards of Care toolkit. The FDA announced plans for an AI-powered early warning system by 2025, aiming to predict shortages before they happen.

The most promising development? Certification for hospital ethics committees. In January 2024, pilot programs began in 15 states to train and certify these teams. They’ll be required to follow national standards, include ethicists, document every decision, and report outcomes.

Hospitals that have adopted full protocols - with committees, training, and transparency - report:

32% fewer disparities in who gets treatment
41% lower clinician moral distress
89% improvement in patient communication

The tools exist. The frameworks are proven. The question is: will hospitals use them?

What Patients and Families Should Know

If you or a loved one is facing a drug shortage, ask these questions:

Is there an alternative medication? (Sometimes a different drug works just as well.)
Can we adjust the dose or schedule? (Lower doses given less often can still be effective.)
Has a committee reviewed this decision? (If not, ask why.)
Am I being told the truth about why I’m not getting this drug?

You have a right to know. And you have a right to ask for a review if you feel the decision was unfair.

What Needs to Change

This isn’t just a medical problem - it’s a systemic one. We can’t keep relying on hospitals to make impossible choices with no support.

We need:

National standards: One set of rules for all hospitals, not 5,000 different ones.
Manufacturer accountability: Require more than 68% of drugmakers to report shortages early.
Investment in supply chains: Diversify production. Don’t let three companies control 80% of critical drugs.
Training for all clinicians: Ethics training shouldn’t be optional. It should be mandatory.

The truth is, we’re not running out of medicine because we can’t make it. We’re running out because we’ve built a system that’s too fragile to handle pressure. And when pressure hits, people - real people - pay the price.

Is it legal to ration medications?

Yes, but only under specific ethical and institutional guidelines. There’s no federal law that bans rationing, but hospitals must follow professional standards set by organizations like ASHP and ASCO. Rationing becomes illegal if it’s based on discrimination - such as race, income, or insurance status - or if patients aren’t informed. The key is transparency, consistency, and fairness.

Why don’t more hospitals have ethics committees for drug shortages?

Budgets, staffing, and lack of leadership support. Many hospitals see ethics committees as optional, not essential. Setting up a committee requires training, time, and money - resources that are already stretched thin. Only 36% of hospitals had standing committees as of 2018. Even fewer include ethicists or patient advocates. Without mandatory standards, there’s little incentive to change.

Can patients appeal a rationing decision?

In theory, yes - if the hospital follows the Accountability for Reasonableness framework. Patients should be told how to request a review. In practice, only 18% of hospitals have a documented appeals process. Most patients don’t know they can ask. Clinicians often don’t know how to guide them. That’s why transparency isn’t just ethical - it’s necessary for trust.

Are there alternatives to rationing drugs?

Yes - and hospitals should try them first. The American Journal of Bioethics recommends a three-step approach: (1) Conservation - use lower doses or extend intervals; (2) Substitution - switch to another effective drug; (3) Rationing - only if the first two fail. Many shortages can be avoided if hospitals use these steps early. But too often, they wait until the last vial is gone.

What can I do if my hospital doesn’t have a rationing plan?

Ask for a meeting with the pharmacy director or ethics committee. Bring data - mention ASCO’s 2023 guidelines and the fact that 82% of hospitals have some kind of shortage policy. Advocate for a committee with patient input. You’re not asking for special treatment - you’re asking for fairness. And that’s a right, not a privilege.